BioTime, Inc. (BTX) Lose -4.87%. Is BTX Still in the Game?

At the moment, the debt-to-equity of BioTime, Inc. (NYSE:BTX) is low, standing at 0.32, a figure that is less than the 21.89 average recorded by the industry.

This strength in their income has affected them and thus decreased their earnings to -$9.50 M. The -41.82% yoy growth of BTX’s revenue has gone down that of the industry average by -89.45%.

Analysts expect decrease in earnings is also on the cards next quarter with an average estimate at -$0.07.

The operating profit margin for BioTime, Inc. (BTX) is 712.56%, a figure which is considered to be strong.

The net profit margin which stood at -611.20 on average in the past 5 years has dropped to -1,412.74 in the last 12 months.

There is little evidence at the moment to justify the expectation of the BTX shares to either perform positively or negatively when compared to other stocks.

Powered by Blogger.